Showing results (781-790 of 2,515) with videos related to
Sort By:
Pageof 252
Diabetes & Metabolic Syndrome|July 18, 2017
Appropriate anthropometric indices of obesity and overweight for diagnosis of metabolic syndrome and its relationship with oxidative stressMehri Delvarianzadeh, Maryam Abbasian, Farideh Khosravi, et al.Diabetes & Metabolic Syndrome|July 16, 2017
Type 2 diabetes patients are more amenable to change following a contextualised diabetes education programme in MalaysiaBadariah Ahmad, Anuar Zaini Md Zain, Quek Kia FattDiabetes & Metabolic Syndrome|January 19, 2023
Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia?Preethika Ekanayake, Sunder MudaliarDiabetes & Metabolic Syndrome|July 30, 2021
A new interventional home care model for COVID management: Virtual Covid IPJothydev Kesavadev, Anjana Basanth, Gopika Krishnan, et al.Diabetes & Metabolic Syndrome|July 30, 2021
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectivesAsirvatham Alwin Robert, Abdulghani Al Saeed, Mohamed Abdulaziz Al DawishDiabetes & Metabolic Syndrome|April 22, 2017
The prevalence of metabolic syndrome among older adults in Ecuador: Results of the SABE surveyCarlos H Orces, Enrique Lopez GavilanezDiabetes & Metabolic Syndrome|April 23, 2017
Gender dependent effects of fasting blood glucose levels and disease duration on biochemical markers in type 2 diabetics: A pilot studyAbhijit A Ghadge, Arundhati G Diwan, Abhay M Harsulkar, et al.Diabetes & Metabolic Syndrome|October 18, 2016
Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative studyH M M Herath, T P Weerarathna, C L Fonseka, et al.Diabetes & Metabolic Syndrome|December 18, 2016
An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetesMartin Buysschaert, Michael Bergman, Donald Yanogo, et al.Diabetes & Metabolic Syndrome|December 18, 2016
Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose loweringHolger Fleischmann, Rüdiger Göke, Peter BramlagePageof 252